GSK to Court: Don't Allow Paxil Plaintiffs to Create Own MDL

PHILADELPHIA - A drug manufacturer named in several Paxil suicide cases pending in a Pennsylvania federal court has accused plaintiffs of creating a de facto MDL and wants the cases transferred to the states where the plaintiffs' alleged injuries occurred. Blain v. SmithKlineBeecham, et al., No. 06-1247 (E.D. Pa.).

GlaxoSmithKline filed a brief March 5 in the U.S. District Court for the Eastern District of Pennsylvania, further supporting its argument to have the cases transferred to the plaintiffs' home states. According to GlaxoSmithKline, the plaintiffs have failed to show why the cases belong in Pennsylvania and have ignored rulings in …